Company intelligence / Profile preview

Servier

Suresnes, Île-de-France, Franceservier.us ↗

Ownership: Private
Employees: ~22000
Development stage: Commercial

Overview

Servier has over six decades of experience with a strong focus on innovation. As of early 2025, its pipeline includes approximately 56 projects, with 34 in clinical development, targeting significant unmet medical needs. Over half have first-in-class potential. The portfolio covers oncology (solid/hematologic), cardiometabolism/venous disease, neurology, and immuno-inflammation. Notable marketed drugs include Lonsurf®, Oncaspar®, Tibsovo®, Coveram®, Diamicron®, Daflon®.[6][8]

Therapeutic areas: OncologyCardiovascularNeurology
Modalities: Small molecules (notably in cardiometabolism, oncology, neurology)Monoclonal antibodies and biologics (especially in oncology)Cell therapies such as allogeneic CAR-T[8]
Industry: Pharma

Drug pipeline

88 assets

indapamide

Approved

87 more assets in the full pipeline.

Request access →

Partnerships

Academic researchers/universities worldwide[1][9]Start-ups & biotech companies for open innovation initiatives[1]Pharmaceutical groups—examples include licensing agreements with Cellectis/CAR-T technology partners like Allogene Therapeutics for cell therapies[8]

Beyond the preview

Go deeper on Servier.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Servier.

Explore the full profile